NCT06781255View on ClinicalTrials.gov

Evaluation of K9 in Subjects With Diabetic Macular Edema (DME)

PHASE1RecruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 13, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

July 31, 2027

Conditions
Diabetic Macular Edema
Interventions
DRUG

Kamuvudine-9

96 mg tablets taken twice a day for 24 weeks

Trial Locations (1)

40506

RECRUITING

University of Kentucky, Lexington

Sponsors
All Listed Sponsors
collaborator

Inflammasome Therapeutics, Inc.

UNKNOWN

lead

Michelle Abou-Jaoude

OTHER